IRVINE, Calif., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to participate in the Lazard Capital Markets Corporate Access Day investor conference in Boston. This conference will allow institutional investors to meet with Endologix but does not include a formal presentation.
